Literature DB >> 1665882

Clinical relevance of oxygen radicals in inflammatory bowel disease--facts and fashion.

H Allgayer1.   

Abstract

Oxygen radicals particularly superoxide and hydroxyl radicals are very reactive species believed to be involved in cell and tissue damage in a variety of diseases including inflammatory bowel disease (IBD). Today there are four major arguments for such a role in IBD: Infiltration of the inflamed intestinal mucosa with myeloperoxidase containing activated neutrophils able to produce superoxide, hydroxyl and hypochlorite, increased chemoluminescence response of peripheral and mucosal phagocytic cells to various stimuli, decreased inflammation following specific scavenger treatment in animal models of colitis and defined radical scavenger and inhibitory properties of drugs, especially aminosalicylates used in the therapy of IBD. In the absence of a specific therapy, radical scavenging and/or inhibition may be an adjunctive modality in IBD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1665882     DOI: 10.1007/bf01645146

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis.

Authors:  Y Shiratora; S Aoki; H Takada; H Kiriyama; K Ohto; K Hai; H Teraoka; S Matano; K Matsumoto; K Kamii
Journal:  Digestion       Date:  1989       Impact factor: 3.216

2.  Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4.

Authors:  E A Lobos; P Sharon; W F Stenson
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

3.  Treatment with 16,16'-dimethyl prostaglandin E2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation.

Authors:  H Allgayer; K Deschryver; W F Stenson
Journal:  Gastroenterology       Date:  1989-05       Impact factor: 22.682

4.  Role of reactive oxygen metabolites in experimental colitis.

Authors:  A Keshavarzian; G Morgan; S Sedghi; J H Gordon; M Doria
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

5.  Use of 3,3,5,5-tetramethyl-1-pyrroline-1-oxide spin trap for the continuous flow ESR monitoring of hydroxyl radical generation in the ischemic and reperfused myocardium.

Authors:  M Culcasi; S Pietri; P J Cozzone
Journal:  Biochem Biophys Res Commun       Date:  1989-11-15       Impact factor: 3.575

Review 6.  Oxygen radicals and human disease.

Authors:  C E Cross; B Halliwell; E T Borish; W A Pryor; B N Ames; R L Saul; J M McCord; D Harman
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

7.  Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.

Authors:  Y Miyachi; A Yoshioka; S Imamura; Y Niwa
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

8.  Superoxide production by Crohn's disease neutrophils.

Authors:  F T Curran; R N Allan; M R Keighley
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

9.  Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content.

Authors:  H W Verspaget; A S Peña; I T Weterman; C B Lamers
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

10.  Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease.

Authors:  P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

View more
  8 in total

1.  Subtractive screening reveals up-regulation of NADPH oxidase expression in Crohn's disease intestinal macrophages.

Authors:  M Hausmann; T Spöttl; T Andus; G Rothe; W Falk; J Schölmerich; H Herfarth; G Rogler
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

2.  In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitis.

Authors:  M Hausmann; F Obermeier; D H Paper; K Balan; N Dunger; K Menzel; W Falk; J Schoelmerich; H Herfarth; G Rogler
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

3.  Influence of disease site and activity on peripheral neutrophil function in inflammatory bowel disease.

Authors:  A D'Odorico; R D'Inca; C Mestriner; V Di Leo; A Ferronato; G C Sturniolo
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

4.  Prevention of acetic acid-induced colitis by desferrithiocin analogs in a rat model.

Authors:  Raymond J Bergeron; Jan Wiegand; William R Weimar; John Nhut Nguyen; Charles A Sninsky
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

5.  A stable nitroxide radical effectively decreases mucosal damage in experimental colitis.

Authors:  F Karmeli; R Eliakim; E Okon; A Samuni; D Rachmilewitz
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

6.  Effect of the antioxidant Mesna (2-mercaptoethane sulfonate) on experimental colitis.

Authors:  T Shusterman; S Sela; H Cohen; B Kristal; W Sbeit; R Reshef
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

7.  Glutamate Transporter GLT-1 Upregulation Attenuates Visceral Nociception and Hyperalgesia via Spinal Mechanisms Not Related to Anti-Inflammatory or Probiotic Effects.

Authors:  Y Lin; K Roman; K D Foust; B K Kaspar; M T Bailey; R L Stephens
Journal:  Pain Res Treat       Date:  2011-12-12

8.  Benefits of Zataria multiflora Boiss in Experimental Model of Mouse Inflammatory Bowel Disease.

Authors:  Leila Ashtaral Nakhai; Azadeh Mohammadirad; Narges Yasa; Bagher Minaie; Shekoufeh Nikfar; Ghazal Ghazanfari; Mohammad Jafar Zamani; Gholamreza Dehghan; Hamidreza Jamshidi; Vahid Shetab Boushehri; Reza Khorasani; Mohammad Abdollahi
Journal:  Evid Based Complement Alternat Med       Date:  2006-09-14       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.